Precigen is trading at $6.78, up 11.51%, with no clear company-specific catalyst identified for the October 29 move. - Precigen announced October 28 that it will report third-quarter results and provide business updates on November 4; the upcoming event does not establish the reason for the gain. - The broader market was lower, and the available context does not support attributing the rise to market-wide sentiment. - No reliable live volume figure is available in the provided price context.